Entering text into the input field will update the search result below
Subscribe

Cyclerion Therapeutics reports Q1 results

May 12, 2023 1:50 AM ETCyclerion Therapeutics, Inc. (CYCN)By: Meghavi Singh, SA News Editor
  • Cyclerion Therapeutics press release (NASDAQ:CYCN): Q1 net loss was approximately $7.0 million for Q1 2023, as compared to approximately $13.0 million for Q1 2022.
  • Cash, cash equivalents, and restricted cash balance on March 31, 2023 was approximately $7.2 million, as compared to approximately $13.4 million on December 31, 2022.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.